Source:http://linkedlifedata.com/resource/pubmed/id/10331493
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0000938,
umls-concept:C0007634,
umls-concept:C0030705,
umls-concept:C0039194,
umls-concept:C0079411,
umls-concept:C0085358,
umls-concept:C0205217,
umls-concept:C0237753,
umls-concept:C0441712,
umls-concept:C1332709,
umls-concept:C1332717,
umls-concept:C1413244,
umls-concept:C1706438,
umls-concept:C2698600
|
pubmed:issue |
5
|
pubmed:dateCreated |
1999-6-7
|
pubmed:abstractText |
According to CD28 molecule expression, CD8+ T cells can be classed as CD28bright, CD28dim, and CD28-. The CD28dim T cells were found to derive from mitogenic stimulated CD28-T cells but also from CD28bright T cells through a mechanism of CD28 down-modulation. Moreover, after prolonged in vitro interleukin-2 stimulation, clonal CD28bright, cells showed a CD28dim expression before further evolution to a stable CD28-phenotype. This loss was concomitant with the disappearance of CD28 mRNA. A study of the cytokine production pattern revealed that CD28dim and CD28- T cell clones produced similar levels of type 1 and type 2 cytokines, which differed from those produced by the CD28bright T cell clones. A high percentage of CD28dim and CD28- cells, with similarities in their cytokine production pattern, were found in the blood samples of HIV-infected patients, as compared to healthy donors. The CD28 down-modulation may account for the increased number of CD8+CD28- T cells in HIV-infected patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0741-5400
|
pubmed:author |
pubmed-author:AusendaSS,
pubmed-author:BalsariAA,
pubmed-author:CarusoAA,
pubmed-author:De FrancescoMM,
pubmed-author:FiorentiniSS,
pubmed-author:GarrafaEE,
pubmed-author:ImbertiLL,
pubmed-author:LicenziatiSS,
pubmed-author:MalacarneFF,
pubmed-author:RicottaDD,
pubmed-author:SimoniniAA,
pubmed-author:SolisA AAA,
pubmed-author:TuranoAA
|
pubmed:issnType |
Print
|
pubmed:volume |
65
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
641-8
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:10331493-Adult,
pubmed-meshheading:10331493-Antigens, CD28,
pubmed-meshheading:10331493-CD8-Positive T-Lymphocytes,
pubmed-meshheading:10331493-Clone Cells,
pubmed-meshheading:10331493-Female,
pubmed-meshheading:10331493-HIV Infections,
pubmed-meshheading:10331493-HIV-1,
pubmed-meshheading:10331493-Humans,
pubmed-meshheading:10331493-Immunophenotyping,
pubmed-meshheading:10331493-Interferon-gamma,
pubmed-meshheading:10331493-Interleukins,
pubmed-meshheading:10331493-Lymphocyte Activation,
pubmed-meshheading:10331493-Male,
pubmed-meshheading:10331493-T-Lymphocyte Subsets
|
pubmed:year |
1999
|
pubmed:articleTitle |
Generation of CD28- cells from long-term-stimulated CD8+CD28+ T cells: a possible mechanism accounting for the increased number of CD8+CD28- T cells in HIV-1-infected patients.
|
pubmed:affiliation |
Institute of Microbiology, Department of Experimental and Applied Medicine, Brescia Medical School, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|